Home › Niet-kleincellige longkanker › Californië › Fullerton
Niet-kleincellige longkanker klinische studies in Fullerton, CA
13 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Fullerton (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekruterenFase 1/2
- Providence - St. Jude Medical Center /ID# 271414, Fullerton
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruterenFase 3
- Providence St. Jude Medical Center ( Site 0106), Fullerton
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center, Fullerton
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Providence Medical Foundation, Fullerton
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruterenFase 3
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
- Providence St. Jude Medical Center, Fullerton
- en nog 1
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekruterenFase 1/2
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
- Providence St. Jude Medical Center, Fullerton
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 1
- Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center, Fullerton
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruterenFase 3
- Providence Medical Foundation, Fullerton
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekruterenFase 3
- St. Jude Medical Center, Fullerton
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
RekruterenFase 1/2
- Providence Medical Foundation, Fullerton
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruterenFase 3
- St. Jude Herritage Medical Group, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekruteren
- St Jude Heritage Medical Group, Fullerton
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Fullerton
- Borstkanker9 studies
- Eierstokkanker6 studies
- Lupus5 studies
- Kanker (alle vormen)5 studies
- Longkanker4 studies
- Aldermeesklierkanker4 studies
- Maagkanker3 studies
- Slokdarmkanker3 studies
- Melanoom3 studies
- Plaveiselcelcarcinoom van hoofd en hals3 studies
- Schizofrenie3 studies
- Colorectale kanker3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.